In Vitro Toxicology Testing Market Analysis, Development, and Forecast by 2031

MARKET OVERVIEW

The scientific examination of the effects of harmful chemical agents on engineered bacteria or mammalian cells is known as in vitro toxicity testing . In the early stages of the discovery of potentially beneficial novel compounds such as therapeutic medications, organic products, and food additives, in vitro toxicity monitoring approaches are used mainly to classify potentially dangerous chemicals and/or to demonstrate the absence of certain toxic properties.

MARKET SCOPE

The "Global In Vitro Toxicology Testing Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the In Vitro Toxicology Testing market with detailed market segmentation by product and service, toxicity endpoints and tests, technology, method, application and geography. The report provides key statistics on the market status of the leading In Vitro Toxicology Testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

• Based on product and service, the global In Vitro Toxicology Testing market is segmented into Assays, Services, Reagents & Labware.
• On the basis of toxicity endpoints and tests, the market is segmented into Absorption, Distribution, Metabolism, and Excretion, Skin Irritation, Corrosion, and Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, Carcinogenicity, Neurotoxicity, Other Toxicity Endpoints & Tests.
• On the basis of technology, the market is segmented into Cell Culture Technologies, High-Throughput Technologies, Cellular Imaging Technologies, Toxicogenomics.
• On the basis of method, the market is segmented into Cellular Assays, Biochemical Assays, EX Vivo Models.
• On the basis of application, the market is segmented into Pharmaceutical and Biopharmaceutical Industry, Cosmetics and Household Products Industry, Food Industry, Chemical Industry.

MARKET DYNAMICS

Drivers

• Socio-ethical concerns of animal testing
• Rising new and promising in vitro technologies
• Increasing demand of such assays in pharmaceutical sector
• Increasing R&D expenditure to detect toxicity at an early stage

Restraints-

• Regulatory agencies' reluctance to accept new ways of demonstrating safety and effectiveness

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The In Vitro Toxicology Testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the In Vitro Toxicology Testing market in these regions.

IMPACT OF COVID-19 ON IN VITRO TOXICOLOGY TESTING MARKET

The human response to the coronavirus pandemic is being led by innovative biopharmaceutical companies. Several global biotech firms are working to characterise the Sars-Cov-2 genome and create a vaccine against it. In contrast to the response to SARS/MERs, biotech companies are investigating SARs-Cov-2 at breakneck speed, investing considerable resources in R&D. With several candidates in clinical trials, the public and private sectors are expected to work together in the near future, at least until a Covid-19 vaccine is created.

MARKET PLAYERS

The report covers key developments in the In Vitro Toxicology Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from In Vitro Toxicology Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for In Vitro Toxicology Testing in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the In Vitro Toxicology Testing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

• Covance, Inc. (A part of Laboratory Corporation of America Holdings)
• Bio-Rad Laboratories, Inc.
• Qiagen
• General Electric
• Eurofins Scientific
• Merck KGaA
• Thermo Fisher Scientific, Inc
• Charles River
• Catalent, Inc
• Promega Corporation.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

In Vitro Toxicology Testing Report Scope